133 related articles for article (PubMed ID: 22419717)
1. WITHDRAWN: TNF-Related Apoptosis-Inducing Ligand TRAIL as a Potential Biomarker for Early Pregnancy Complications.
Rull K; Tomberg K; Kõks S; Männik J; Möls M; Sirotkina M; Värv S; Laan M
J Clin Endocrinol Metab; 2012 Jun; ():. PubMed ID: 22419717
[TBL] [Abstract][Full Text] [Related]
2. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm.
Lonergan M; Aponso D; Marvin KW; Helliwell RJ; Sato TA; Mitchell MD; Chaiwaropongsa T; Romero R; Keelan JA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3835-44. PubMed ID: 12915677
[TBL] [Abstract][Full Text] [Related]
5. A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL).
Bai X; Williams JL; Greenwood SL; Baker PN; Aplin JD; Crocker IP
Placenta; 2009 Oct; 30(10):855-60. PubMed ID: 19674787
[TBL] [Abstract][Full Text] [Related]
6. TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.
Perri P; Zauli G; Gonelli A; Milani D; Celeghini C; Lamberti G; Secchiero P
Biomed Res Int; 2015; 2015():424019. PubMed ID: 25834817
[TBL] [Abstract][Full Text] [Related]
7. TNF-related Apoptosis-inducing Ligand Delivered by rNDV is a Novel Agent for Cancer Gene Therapy.
Bai FL; Tian H; Yu YH; Yin JC; Ren GP; Zhou B; Li DS
Technol Cancer Res Treat; 2015 Dec; 14(6):737-46. PubMed ID: 24988059
[TBL] [Abstract][Full Text] [Related]
8. TNF-related apoptosis-inducing ligand (TRAIL) promotes trophoblast cell invasion via miR-146a-EGFR/CXCR4 axis: A novel mechanism for preeclampsia?
Xiao C; Rui Y; Zhou S; Huang Y; Wei Y; Wang Z
Placenta; 2020 Apr; 93():8-16. PubMed ID: 32090966
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
Mongkolsapaya J; Cowper AE; Xu XN; Morris G; McMichael AJ; Bell JI; Screaton GR
J Immunol; 1998 Jan; 160(1):3-6. PubMed ID: 9551946
[TBL] [Abstract][Full Text] [Related]
10. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
11. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
[TBL] [Abstract][Full Text] [Related]
13. Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis.
Kutlu O; Akkaya E; Koksal IT; Bassorgun IC; Ciftcioglu MA; Sanlioglu S; Kukul E
Int Urol Nephrol; 2010 Jun; 42(2):393-9. PubMed ID: 19705295
[TBL] [Abstract][Full Text] [Related]
14. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
15. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
Keogh RJ; Harris LK; Freeman A; Baker PN; Aplin JD; Whitley GS; Cartwright JE
Circ Res; 2007 Mar; 100(6):834-41. PubMed ID: 17322170
[TBL] [Abstract][Full Text] [Related]
16. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
[TBL] [Abstract][Full Text] [Related]
17. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
Steinwede K; Henken S; Bohling J; Maus R; Ueberberg B; Brumshagen C; Brincks EL; Griffith TS; Welte T; Maus UA
J Exp Med; 2012 Oct; 209(11):1937-52. PubMed ID: 23071253
[TBL] [Abstract][Full Text] [Related]
18. Effects of A.marina-Derived Isoquercitrin on TNF-Related Apoptosis-Inducing Ligand Receptor (TRAIL-R) Expression and Apoptosis Induction in Cervical Cancer Cells.
Arumugam S; Bandil K; Proksch P; Murugiyan K; Bharadwaj M
Appl Biochem Biotechnol; 2017 Jun; 182(2):697-707. PubMed ID: 28013431
[TBL] [Abstract][Full Text] [Related]
19. Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib.
Edagawa M; Kawauchi J; Hirata M; Goshima H; Inoue M; Okamoto T; Murakami A; Maehara Y; Kitajima S
J Biol Chem; 2014 Aug; 289(31):21544-61. PubMed ID: 24939851
[TBL] [Abstract][Full Text] [Related]
20. Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages.
Je H; Nam GH; Kim GB; Kim W; Kim SR; Kim IS; Lee EJ
J Control Release; 2021 Mar; 331():7-18. PubMed ID: 33450317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
